Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presents its innovations in treating fluid overload across liver disease, heart failure, and cancer. The company develops the alfapump® system for refractory ascites and DSR® therapy, with regulatory approvals in Europe and ongoing clinical investigations in the US and Canada.
conference
21 Pages
investor_presentation
37 Pages
VERCOM S.A.
Cabot Oil & Gas Investor Presentation — May 2021
investor_presentationinvestor_presentation
18 Pages
Cabot Oil & Gas Corporation
Amur Capital Income Fund 2023 Investor Presentation
investor_presentationinvestor_presentation
23 Pages
Amur Capital Income Fund Inc.